View Author
women group testing cytology screening round hpv dna testing result lesion cin 3+ lesions hrhpv control group number cytological baseline study cancer intervention group follow-up cin 3+ control intervention referral cin 2+ pathology baseline round month hpv dna cytological testing papillomaviru cytological results dyskaryosi trial detection cin 3+ cases netherland 18 months table smear colposcopy endometrial pathology outpatient hrhpv-testing gynecology outpatient clinic hpv testing cin 2+ lesions intake rozendaal l screening round clinic vu university cancer screening papillomavirus testing screening programme department gynecology meijer hrhpv test rozendaal bmdb hrhpv speci ficity reason university referral reason cin 2/3+ lesions endometrial hpv dna test cin 3+ risk analyses amsterdam snijder screening rounds 5 years outpatient clinic 2/3+ group 1 di fferences meijer cj study groups 42 months
2 Most Recent Publications
|
HrHPV-testing in a university hospital gynecology outpatient clinic: Recommendations for clinical practice
(Article)
Louwers, J.A. Berkhof, J. Zaal, A. Kocken, M. Rozendaal, L. Heideman, D.A.M. Baal, W.M. van Snijders, P.J.F. Verheijen, R.H.M. Meijer, C.J.L.M. |
2012-03-01
|
|
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
(Article)
Bulkmans, N. Berkhof, J. Ruitinga, W. Ballegooijen, M. van Snijders, P.J.F. Meijer, C.J.L.M. Rozendaal, L. Kemenade, F. van Boeke, A. Bulk, S. Voorhorst, F. Verheijen, R. Groningen, K. van Boon, M. |
2007-11-24
|